Arcus Biosciences Inc (RCUS)
Fixed asset turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 258,000 | 263,000 | 247,000 | 237,000 | 117,000 | 119,355 | 121,236 | 118,995 | 112,000 | 433,144 | 408,724 | 399,137 | 398,304 | 53,292 | 108,361 | 92,939 | 77,517 | 77,780 | 15,000 | 15,000 |
| Property, plant and equipment | US$ in thousands | 47,000 | 48,000 | 49,000 | 51,000 | 51,000 | 50,000 | 45,000 | 37,000 | 35,000 | 33,892 | 33,416 | 33,481 | 32,000 | 28,818 | 23,806 | 14,849 | 10,807 | 8,728 | 8,264 | 8,761 |
| Fixed asset turnover | 5.49 | 5.48 | 5.04 | 4.65 | 2.29 | 2.39 | 2.69 | 3.22 | 3.20 | 12.78 | 12.23 | 11.92 | 12.45 | 1.85 | 4.55 | 6.26 | 7.17 | 8.91 | 1.82 | 1.71 |
December 31, 2024 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $258,000K ÷ $47,000K
= 5.49
The fixed asset turnover ratio indicates how efficiently a company is generating revenue from its fixed assets. A higher ratio typically signifies that the company is effectively utilizing its fixed assets to generate sales.
Analyzing Arcus Biosciences Inc's fixed asset turnover ratio over the stated periods reveals fluctuations in their asset utilization efficiency. From March 31, 2020, to September 30, 2021, the ratio was relatively stable, ranging between 1.71 and 8.91. Notably, there was a significant spike in the ratio as of September 30, 2020, indicating a substantial increase in revenue generated per fixed asset during that period.
Subsequently, the ratio experienced a decline from December 31, 2021, to March 31, 2023, fluctuating between 2.29 and 12.45. This downturn suggests potential inefficiencies in asset utilization or fluctuations in revenue generation during this period.
From March 31, 2023, to December 31, 2024, there was another phase of fluctuation in the fixed asset turnover ratio, ranging from 2.29 to 5.49. This volatility signifies ongoing changes in how effectively Arcus Biosciences Inc is utilizing its fixed assets to generate sales.
Overall, the analysis of Arcus Biosciences Inc's fixed asset turnover ratio highlights varying levels of efficiency in utilizing fixed assets to generate revenue over the specified time frame. It would be beneficial for stakeholders to further investigate the underlying factors contributing to these fluctuations to understand the company's operational performance and potential areas for improvement.
Peer comparison
Dec 31, 2024